Three more firms to launch home testing kits for coronavirus: ICMR chief

Addressing a briefing on the coronavirus situation, Dr Balram Bhargava said that the government is targeting 2.5 million tests by the end of this month and 4.5 million tests by the end of June

ICMR chief Dr Balram Bhargava
Photo: ANI
BS Web Team New Delhi
2 min read Last Updated : May 20 2021 | 5:39 PM IST
Rapid Antigen Tests for coronavirus should be conducted in large numbers as it gives results quickly, which will in turn help in isolating patients during early stages of the disease, Dr Balram Bhargava said on Thursday.

Addressing a briefing on the coronavirus situation in the country, the ICMR chief said that the government is targeting 2.5 million tests by the end of this month and 4.5 million tests by the end of June.

Dr Bhargava further said he expects home testing kit to be available within three-four days and three more companies are expected to launch self testing kits for coronavirus.
Mylab Discovery Solutions has won approval for India's first self-use rapid test. The Pune-based company’s CoviSelf test can be used by symptomatic individuals and immediate contacts. It costs Rs 250 per kit and gives results in 15 minutes.

MyLab has said the test will be available for use next week in more than 700,000 pharmacies across India.

Explaining the process of how to use the test kit, the ICMR chief said: "Step 1 is that you buy the test kit from a chemist; Step 2- download mobile app; Step 3- conduct the test at home; step 4- click mobile image and upload, test result will be given. Within 3-4 days this should be available in the market."

MyLab’s self-use kit will cost Rs 250 and will be available for purchase at all major pharmacies without a prescription.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story